Rankings
▼
Calendar
LNTH Q4 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
Q4 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$86M
+6.2% YoY
Gross Profit
$44M
50.8% margin
Operating Income
$17M
19.6% margin
Net Income
$13M
15.4% margin
EPS (Diluted)
$0.34
QoQ Revenue Growth
-3.0%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$440M
Total Liabilities
$369M
Stockholders' Equity
$71M
Cash & Equivalents
$113M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$86M
$81M
+6.2%
Gross Profit
$44M
$38M
+15.7%
Operating Income
$17M
$9M
+84.0%
Net Income
$13M
$97M
-86.3%
Revenue Segments
US Segment
$73M
84%
International Segment
$14M
16%
← FY 2018
All Quarters
Q1 2019 →